Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2910 of 5804
-
New device brings relief to dry eye sufferers
Symptom relief CompletedIn this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Liver's Post-Meal secrets could unlock new fatty liver treatments
Knowledge-focused CompletedFatty liver disease is a globally widespread disease. The identification of valid biomarkers and targets for potential treatments requires in-depth knowledge about the pathophysiology of the postprandial liver. The study will consist of seven work packages (WP) including blood te…
Phase: NA • Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Chin surgery showdown: can a Mini-Wing reshape both face and airway?
Symptom relief OngoingThis retrospective cohort study aims to compare the effects of Mini Wing and Box genioplasty performed in conjunction with bimaxillary orthognathic surgery on upper airway area and soft tissue profile in adult patients with skeletal Class II dentofacial deformity. Preoperative an…
Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Needles vs. inflammation: acupuncture tested in kids with Crohn's and colitis
Symptom relief OngoingChronic inflammatory bowel disease (CIBD) with its prevalence of 2.6 million people in Europe is diagnosed in 25% before the age of 18 years. Early remission is intended to improve child growth, quality of life and reduce psychological comorbidities. Additionally to conventional …
Phase: NA • Sponsor: Medical University of Vienna • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Smartphone app aims to land blood pressure safely
Disease control OngoingHypertension (HTN) is the most important stroke and cardiovascular disease (CVD) risk factor. Unfortunately, there is substantial under-treatment of HTN. Of the 86 million adults with prevalent HTN in the U.S., 40 million (46%) have inadequately controlled blood pressure (BP). Th…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
One leg at a time: new exercise hope for lung disease patients
Symptom relief OngoingIdiopathic pulmonary fibrosis (IPF) is a lung disease that limits the ability to breathe enough for a good workout. One way to improve the exercise training is to reduce the number of muscles being trained together. By training one leg at a time, the patient does not have to brea…
Phase: NA • Sponsor: West Park Healthcare Centre • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Short bone drug boost may tighten spine screws in osteoporosis patients
Disease control OngoingThis project aims to investigate any difference of insertional torque strength for osteoporotic patients with preoperative 1-month teriparatide injections versus those without. The increased insertional torque of pedicle screws during surgery after only 1 month of teriparatide us…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New study aims to find best dose of privigen for kids with nerve disorder
Disease control Recruiting nowA randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental drug aims to stop rare heart disease in its tracks
Disease control TerminatedTransthyretin is a protein produced in the liver that transports thyroid hormone and vitamin A. A single substitution of an amino acid in the structure of TTR can result in a relatively unstable protein, the breakdown products of which (predominantly monomers) aggregate abnormall…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug switch may stop shakes in transplant patients
Disease control Recruiting nowThis is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.
Phase: PHASE2, PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can an antidepressant also fight chemo nausea? new study tests mirtazapine in brain cancer patients
Symptom relief OngoingThe purpose of the study is to estimate the ability of mirtazapine to reduce depression, nausea, and vomiting, and maintain weight in depressed glioma patients undergoing Temozolomide (TMZ) therapy. Of equal importance, the investigators will monitor the tolerability of Mirtazapi…
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis phase I trial studies the best dose and how well copanlisib when given together with nivolumab works in treating patients with Richter's transformation or transformed indolent non-Hodgkin lymphoma. Copanlisib may stop the growth of tumor cells by blocking some of the enzymes…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New CT tool could spot hidden fracture risk in COPD patients
Knowledge-focused CompletedThe goal of this translational study is to establish a newly emerging CT-based tool for the characterization of changes in bone micro-architecture and assessment of their implications for fracture-risk in a population of COPD patients at risk for osteoporosis. The tool will be su…
Phase: NA • Sponsor: Punam K Saha • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Promising combo for brain metastases hits early snag: trial ends early
Disease control TerminatedThis research study is studying a drug called GDC-0084 as a possible treatment for HER2-Positive Breast Cancer. The drugs involved in this study are: * GDC-0084 * Trastuzumab (Herceptin®)
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Antibiotic boosts chemo against tough pancreatic cancer?
Disease control OngoingThis is a single-center, pilot study evaluating the addition of Ciprofloxacin (study drug) to standard-of-care gemcitabine and nab-paclitaxel chemotherapy in treatment-naïve metastatic PDAC patients. Patients who are recommended gemcitabine and nab-paclitaxel chemotherapy as a st…
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Biomarkers may guide personalized pain relief for kids
Knowledge-focused CompletedThe purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Experimental combo aims to rally immune system against tough liver cancer
Disease control OngoingThis phase Ib trial studies the side effects and best dose of IRX-2 when given together with cyclophosphamide and nivolumab in treating patients with liver cancer that has come back or spread to other parts of the body and does not response to treatment. Biological therapies, suc…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New study aims to cut opioid use after bone surgery
Symptom relief Recruiting nowNationally, the opioid crisis has become a major epidemic with increasing mortality rates each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic oncology,…
Phase: PHASE3 • Sponsor: St. Louis University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New prosthetic tech aims to stop sweat and slipping for amputees
Symptom relief CompletedIndividuals with lower limb amputation often complain about uncomfortable residual limb skin temperatures and the accumulation of sweat inside their prostheses. It doesn't take long before the presence of sweat on the residual limb leads to a lack of confidence in the security of…
Phase: NA • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo shows promise in preventing transplant complications
Disease control CompletedThe purpose of this study is to examine the safety and efficacy of the addition of BMS-986004 to standard of care Sirolimus (SIR)-based immune suppression.
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC